₹ 27.7 Cr
Volume Transacted
(Dec 20, 2024)
206.5 K
Stocks Traded
(Dec 20, 2024)
Last Updated on: Dec 23, 2024
Dr Reddys Laboratories Ltd
NSE: DRREDDY
Net Profit
₹ 1341.9
Last updated on: Dec 23, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
20 Dec 2024 | 1342.45 | 1328.95 | 1368 | 1318.35 |
19 Dec 2024 | 1326 | 1270.05 | 1330.45 | 1270.05 |
18 Dec 2024 | 1275.05 | 1267.95 | 1280.7 | 1250.1 |
17 Dec 2024 | 1248 | 1269.95 | 1270.4 | 1243.75 |
16 Dec 2024 | 1269.9 | 1246.3 | 1272.9 | 1245.25 |
13 Dec 2024 | 1246.3 | 1242.95 | 1250 | 1227 |
12 Dec 2024 | 1245.95 | 1245.9 | 1249.75 | 1226.4 |
11 Dec 2024 | 1238.45 | 1247.8 | 1247.8 | 1226.5 |
10 Dec 2024 | 1239.95 | 1254.8 | 1254.8 | 1233 |
09 Dec 2024 | 1254.8 | 1261.3 | 1261.8 | 1244 |
Date | Price (₹) |
---|---|
20 Dec 2024 | 1342.45 |
19 Dec 2024 | 1326 |
18 Dec 2024 | 1275.05 |
17 Dec 2024 | 1248 |
16 Dec 2024 | 1269.9 |
13 Dec 2024 | 1246.3 |
12 Dec 2024 | 1245.95 |
11 Dec 2024 | 1238.45 |
10 Dec 2024 | 1239.95 |
09 Dec 2024 | 1254.8 |
Historical Revenue of Dr Reddys Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Dr Reddys Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Dr Reddys Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Dr Reddys Laboratories allots 13,080 equity shares under ESOS
Dr Reddys Laboratories has allotted 13,080 equity shares under ESOS on 19 December 2024. P...
20 Dec 2024 09:31
Dr Reddys Laboratories Ltd gains for third straight session
Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...
20 Dec 2024 13:05
Dr Reddys launches immuno-oncology drug - Toripalimab in India
Dr Reddys Laboratories announced the launch of Toripalimab in India. Toripalimab is a New ...
28 Nov 2024 09:14
Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India
Toripalimab is the only immuno-oncology drug approved by various regulatory authorities ar...
28 Nov 2024 10:11
DRL slips after Hyderabad facility gets 7 observations from USFDA
The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...
21 Nov 2024 10:23
DRL's Hyderabad facility gets 7 observations from USFDA
The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...
20 Nov 2024 10:40
Concalls
Aug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptMay 2020
TranscriptJan 2020
TranscriptAug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptMay 2020
TranscriptJan 2020
TranscriptUnlimited trading starting at just Rs. 249*